XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2024
shares
Sep. 30, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Merdad V. Parsey [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On August 28, 2024, Merdad V. Parsey, M.D., Ph.D., our Chief Medical Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) under the Exchange Act to sell, subject to certain conditions, through April 8, 2025: (a) up to 395,164 shares of our common stock; and (b) 40% of the net vested shares of our common stock to be issued to Dr. Parsey in connection with the potential vesting and settlement of certain performance stock units.
Name Merdad V. Parsey  
Title Chief Medical Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 28, 2024  
Expiration Date April 8, 2025  
Arrangement Duration 223 days  
Aggregate Available 395,164 395,164
Andrew Dickinson [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On August 29, 2024, Andrew Dickinson, our Chief Financial Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) under the Exchange Act to sell up to 695,164 shares of our common stock through November 29, 2026, subject to certain conditions.
Name Andrew Dickinson  
Title Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 29, 2024  
Expiration Date November 29, 2026  
Arrangement Duration 822 days  
Aggregate Available 695,164 695,164